ns 2028 has been researched along with s-nitroso-n-acetylpenicillamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Berg, A; Ericson, AC; Grenegård, M; Redéen, S; Sjöstrand, SE | 1 |
| Detmar, M; Drinnenberg, I; Huggenberger, R; Kajiya, K; Ma, B | 1 |
3 other study(ies) available for ns 2028 and s-nitroso-n-acetylpenicillamine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Nitric oxide inhibits gastric acid secretion by increasing intraparietal cell levels of cGMP in isolated human gastric glands.
Topics: Adult; Cyclic GMP; Dibutyryl Cyclic GMP; Gastric Acid; Guanylate Cyclase; Histamine; Histamine Antagonists; Humans; Male; Nitric Oxide; Oxadiazoles; Oxazines; Parietal Cells, Gastric; S-Nitroso-N-Acetylpenicillamine | 2005 |
Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation.
Topics: Cell Movement; Cell Proliferation; Cells, Cultured; Cyclic GMP; Edema; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Guanylate Cyclase; Humans; Immunity, Cellular; Inflammation; Lymphatic Vessels; Nitric Oxide; Nitric Oxide Synthase Type III; Oxadiazoles; Oxazines; Receptors, Cytoplasmic and Nuclear; S-Nitroso-N-Acetylpenicillamine; Soluble Guanylyl Cyclase | 2008 |